Notice Information
Notice Title
Provision of Testing Services and Sample Analysis as part of the National Immunisation Programme Study
Notice Description
PHE has been tasked by DHSC to urgently undertake a study to evaluate the immune response following COVID-19 vaccines as part of the National Immunisation Programme. This has been identified as a high national public health priority and a key aspect of this study requires taking 2000 samples for cellular work over a 24-month period. The UK Vaccines Taskforce have selected Oxford Immunotec as the sole supplier of T cell Testing for SARS-CoV-2 specific responses as part of the new COVID vaccine trials. Aligning PHE's study with this decision will ensure that it is consistent with the other vaccine studies performed within the UK, providing for comprehensive comparison and analysis to be carried out across all the different studies.
Lot Information
Lot 1
Oxford Immunotec will provide testing services and sample analysis to assist PHE in its evaluation of immune responses following COVID-19 vaccines used in the National Immunisation Programme.
Procurement Information
The justification to source these services from Oxford Immunotec is to enable PHE to adhere with the decision made by the UK Vaccines Taskforce who selected Oxford Immunotec as the sole supplier of T cell Testing for SARS-CoV-2 specific responses as part of the new COVID vaccine trials. Oxford Immunotec was chosen as a result of the competitive process for its expertise in T cell measurement and its unique ability to provide T-SPOT(r) technology, the only globally regulated ELISPOT platform - which is currently being used clinically for identifying T cells made in response to another respiratory pathogen responsible for Tuberculosis. Aligning with this verdict will ensure that the National Immunisation Programme being carried out by PHE is consistent with the other vaccine studies performed within the UK, providing for comprehensive comparison and analysis to be carried out across all the different studies. The Vaccines Taskforce has emphasised that it is important to be able to assess the different vaccines head-to-head and employing Oxford Immunotec's T-SPOT technology will measure the magnitude of the SARS-CoV-2 protein-specific T cell response of different vaccine candidates for cross-comparisons.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-029b7d
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/005132-2021
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
71 - Architectural, construction, engineering and inspection services
-
- CPV Codes
71900000 - Laboratory services
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £240,000 £100K-£500K
Notice Dates
- Publication Date
- 13 Mar 20214 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 9 Feb 20215 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- PUBLIC HEALTH ENGLAND
- Contact Name
- Not specified
- Contact Email
- tee.agbo@phe.gov.uk
- Contact Phone
- Not specified
Buyer Location
- Locality
- SALISBURY
- Postcode
- SP2 0QT
- Post Town
- Salisbury
- Country
- England
-
- Major Region (ITL 1)
- TLK South West (England)
- Basic Region (ITL 2)
- TLK7 Gloucestershire and Wiltshire
- Small Region (ITL 3)
- TLK72 Wiltshire
- Delivery Location
- Not specified
-
- Local Authority
- Wiltshire
- Electoral Ward
- Till Valley
- Westminster Constituency
- East Wiltshire
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-029b7d-2021-03-13T22:56:02Z",
"date": "2021-03-13T22:56:02Z",
"ocid": "ocds-h6vhtk-029b7d",
"initiationType": "tender",
"tender": {
"id": "ocds-h6vhtk-029b7d",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Provision of Testing Services and Sample Analysis as part of the National Immunisation Programme Study",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "71900000",
"description": "Laboratory services"
},
"mainProcurementCategory": "services",
"description": "PHE has been tasked by DHSC to urgently undertake a study to evaluate the immune response following COVID-19 vaccines as part of the National Immunisation Programme. This has been identified as a high national public health priority and a key aspect of this study requires taking 2000 samples for cellular work over a 24-month period. The UK Vaccines Taskforce have selected Oxford Immunotec as the sole supplier of T cell Testing for SARS-CoV-2 specific responses as part of the new COVID vaccine trials. Aligning PHE's study with this decision will ensure that it is consistent with the other vaccine studies performed within the UK, providing for comprehensive comparison and analysis to be carried out across all the different studies.",
"lots": [
{
"id": "1",
"description": "Oxford Immunotec will provide testing services and sample analysis to assist PHE in its evaluation of immune responses following COVID-19 vaccines used in the National Immunisation Programme.",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
},
"hasOptions": false,
"status": "cancelled"
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UK"
}
],
"relatedLot": "1"
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"coveredBy": [
"GPA"
],
"procurementMethodRationaleClassifications": [
{
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"id": "D_TECHNICAL",
"description": "The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons"
}
],
"procurementMethodRationale": "The justification to source these services from Oxford Immunotec is to enable PHE to adhere with the decision made by the UK Vaccines Taskforce who selected Oxford Immunotec as the sole supplier of T cell Testing for SARS-CoV-2 specific responses as part of the new COVID vaccine trials. Oxford Immunotec was chosen as a result of the competitive process for its expertise in T cell measurement and its unique ability to provide T-SPOT(r) technology, the only globally regulated ELISPOT platform - which is currently being used clinically for identifying T cells made in response to another respiratory pathogen responsible for Tuberculosis. Aligning with this verdict will ensure that the National Immunisation Programme being carried out by PHE is consistent with the other vaccine studies performed within the UK, providing for comprehensive comparison and analysis to be carried out across all the different studies. The Vaccines Taskforce has emphasised that it is important to be able to assess the different vaccines head-to-head and employing Oxford Immunotec's T-SPOT technology will measure the magnitude of the SARS-CoV-2 protein-specific T cell response of different vaccine candidates for cross-comparisons."
},
"awards": [
{
"id": "005132-2021-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-8690",
"name": "Oxford Immunotec Ltd"
}
]
}
],
"parties": [
{
"id": "GB-FTS-2800",
"name": "Public Health England",
"identifier": {
"legalName": "Public Health England"
},
"address": {
"streetAddress": "Manor Farm Road, Porton Down",
"locality": "Salisbury",
"region": "UK",
"postalCode": "SP2 0QT",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "tee.agbo@phe.gov.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.gov.uk/government/organisations/public-health-england",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "MINISTRY",
"description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-8690",
"name": "Oxford Immunotec Ltd",
"identifier": {
"legalName": "Oxford Immunotec Ltd"
},
"address": {
"streetAddress": "94C Innovation Drive",
"locality": "Abingdon",
"region": "UK",
"postalCode": "OX14 4RZ",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-5202",
"name": "High Court and Court of Appeal of England and Wales",
"identifier": {
"legalName": "High Court and Court of Appeal of England and Wales"
},
"address": {
"streetAddress": "Strand",
"locality": "London",
"postalCode": "WC2A 2LL",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"id": "GB-FTS-2800",
"name": "Public Health England"
},
"contracts": [
{
"id": "005132-2021-1",
"awardID": "005132-2021-1",
"status": "active",
"value": {
"amount": 240000,
"currency": "GBP"
},
"dateSigned": "2021-02-09T00:00:00Z"
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 1
}
]
},
"language": "en"
}